The Use of Noninvasive Velacur® for Discriminating between Volunteers and Patients with Chronic Liver Disease: A Feasibility Study by Michael P. Curry, Edward Tam, Caitlin Schneider, Noha Abdelgelil, Tarek Hassanien, Nezam H. Afdhal

Get full text

Type 2 diabetes complications are associated with liver fibrosis independent of hemoglobin A1c by Hirsh D. Trivedi, Qua Tran, Zachary Fricker, Michael P. Curry, Jonathan X. Li, Michelle Lai

Get full text

Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies by Michael P. Curry, Hugo E. Vargas, Alex S. Befeler, Nikolaos T. Pyrsopoulos, Vilas R. Patwardhan, Khurram Jamil

Get full text

Prevalence of High Liver Stiffness and a Screening Strategy Using the SODA‐2B Score Among US Adults by Sebastian Niezen, Elliot B. Tapper, Hirsh Trivedi, Michelle Lai, Michael P. Curry, Kenneth J. Mukamal, Z. Gordon Jiang

Get full text

Methods and validation of velacur determined fat fraction in patients with MASLD by Mohammad Honarvar, Julio Lobo, Caitlin Schneider, Samuel Klein, Gordon I. Smith, Rohit Loomba, Alnoor Ramji, Tarek Hassanein, Eric M. Yoshida, Emily Pang, Michael P. Curry, Nezam H. Afdhal

Get full text

First‐line therapies for hepatitis B in the United States: A 3‐year prospective and multicenter real‐world study after approval of tenofovir alefenamide by Calvin Q. Pan, Nezam H. Afdhal, Victor Ankoma‐Sey, Ho Bae, Michael P. Curry, Douglas Dieterich, Lynn Frazier, Andrew Frick, Hie‐Won Hann, W. Ray Kim, Paul Kwo, Scott Milligan, Myron J. Tong, K. Rajender Reddy

Get full text

Advancing diagnosis and management of liver disease in adults through exome sequencingResearch in context by Melanie Zheng, Aaron Hakim, Chigoziri Konkwo, Aimee M. Deaton, Lucas D. Ward, Marina G. Silveira, David N. Assis, AnnMarie Liapakis, Ariel Jaffe, Z. Gordon Jiang, Michael P. Curry, Michelle Lai, Michael H. Cho, Daniel Dykas, Allen Bale, Pramod K. Mistry, Silvia Vilarinho

Get full text